Disease management is used to manage patients who have asthma and who are enrolled in a managed care health plan. To understand the effect of disease management on asthma severity and utilization, we will review data from a Medicaid HMO to determine the number of health plan members with different asthma severities and what their outcomes are. This will help us to improve the service provided to these patients. I wish to publish this so that other health plans can benefit from our experience.

Condition	Intervention
Asthma	Behavior: Education of providers and their staff  Behavior: Case Management  Behavior: Payment for desired behaviors

Further Study Details: 

Disease management is used to manage patients who have asthma and who are enrolled in a managed care health plan. To understand the effect of disease management on asthma severity and utilization, we will review data from a Medicaid HMO to determine the number of health plan members with different asthma severities and what their outcomes are. This will help us to improve the service provided to these patients.

Data on subjects already exists in the Health Management database. We will use data that has been collected between January 1, 2000 and August 18, 2005. We will use a convenience sample consisting of available subjects meeting the program criteria. The total FHP database includes approximately 50,000 members from which approximately 6,000 have been identified as having asthma.

We will create a research database that will not contain any patient-specific data. Instead, an intermediate workstation will be programmed to query the health management database and send the resulting aggregated and de-identified data to the research database for analysis on another workstation. The research database will never contain any patient identifiers nor will it contain individual patient data. It only will contain aggregated data provided by the intermediate query workstation.

Here is a complete list of variables that will be housed in the research database for subsequent analysis:

Categorical variables: Asthma severity (intermittent, mild, moderate or severe persistent), Provider office, Quarter when seen, Medication type (controller or reliever), Age category (0-4, 5-9, 10-17, >17years), active status (active or inactive), Location (ER, Inpatient, Routine visit), Case managed (yes, no), Gender, Psychosocial issues, Diagnosis (asthma, not asthma)

Continuous variables: Cost of care, Number of visits, Number of prescriptions, Number of members in the above categories, Mean Quality of life

Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• Health Plan members who have undergone disease management and who have a diagnosis of asthma (ICD9 code of 493.xx)

Exclusion Criteria:

• None

Missouri
      Children''''s Mercy Hospitals & Clinics, Kansas City,  Missouri,  64108,  United States

Study chairs or principal investigators

Jay M Portnoy, MD,  Principal Investigator,  Children''''s Mercy Hospitals & Clinics   

Study ID Numbers:  05 08-110X
Last Updated:  August 29, 2005
Record first received:  August 29, 2005
ClinicalTrials.gov Identifier:  NCT00137722
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-08-30